1 |1 | Countries using and planning to introduce IPV

2 |2 | Countries using and planning to introduce IPV June 2015 status report This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine (IPV). Information here is updated monthly based on information shared by WHO and UNICEF Regional Offices. Please contact with any questions or updates on this Definitions Formal decision to introduce: The country has documentation of its decision to introduce IPV which has been verified by the relevant WHO Regional Office, or for GAVI eligible countries, a complete application for IPV has been submitted to the GAVI Secretariat. Intent to introduce: The country has informally indicated that it plans to introduce IPV, e.g. planning an application to GAVI, or by requesting technical assistance to develop an IPV introduction plan. Tracking these decisions and informal intents provide an indication of the global trend towards meeting the targets of the Polio Eradication and Endgame Strategic Plan.

3 |3 | Countries using IPV vaccine to date and formal decision/intent to introduce Since January 2013, the following countries have introduced IPV: Kazakhstan & Peru (July 2013); Libya (March 2014); Albania (May 2014); Panama (July 2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & Nigeria (February 2015); Bangladesh & Maldives (March 2015); DPR Korea, DR Congo & Gambia (April 2015); Madagascar & Sudan (May 2015) Data source: WHO/IVB Database, as of 01 June 2015 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization Date of slide: 1 June 2015 The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved. Introduced* to date(89 countries or 46%) Formal commitment to introduce in 2015 (91 countries or 47%) (4 countries or 2%) Formal commitment to introduce in 2016(10 countries or 5%) Not Available / Not introduced / No Plans Not applicable Intend to introduce in 2015 (Cook Islands, Fiji, Mauritius, Thailand) * Includes introductions in some parts of the country only

4 |4 | Countries using IPV vaccine to date and introductions planned according to Gavi eligibility status Since January 2013, the following countries have introduced IPV: Kazakhstan & Peru (July 2013); Libya (March 2014); Albania (May 2014); Panama (July 2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & Nigeria (February 2015); Bangladesh & Maldives (March 2015); DPR Korea, DR Congo & Gambia (April 2015);Madagascar & Sudan (May 2015) Data source: WHO/IVB Database, as of 01 June 2015 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization Date of slide: 1 June 2015 The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved. Introduced* to date(89 countries or 46%) Gavi countries with formal commitment to introduce in (62 countries or 32%) Non Gavi countries with formal commitment to introduce in (39 countries or 20.1%) Non Gavi countries with intent to introduce in 2015 (Cook Islands, Fiji, Mauritius, Thailand) (4 countries or 2%) Not Available / Not introduced / No Plans Not applicable * Includes introductions in some parts of the country only

5 |5 | 105 countries introducing IPV between June 2015 and January 2016 Tier 1 countries are countries with cVDPV2 transmission or cVDPV2 reported since 2000 & WPV endemic countries Tier 2 countries are countries with cVDPV 1/3 since 2000 or large /medium size countries with DTP3 coverage <80% in the past 3 years as per WUENIC Source: WHO/UNICEF database as at 01 June 2015 Yemen and Mauritius are introducing in 2015 but no month of introduction available.

6 |6 | Tier 1 and 2 Countries using IPV vaccine to date and formal decision to introduce Tier 1 countries are countries with cVDPV2 transmission or cVDPV2 reported since 2000 & WPV endemic countries Tier 2 countries are countries with cVDPV 1/3 since 2000 or large /Medium size countries with DTP3 coverage <80% in the past 3 years as per WUENIC Since January 2013, the following Tier 1 and 2 countries have introduced IPV: The Philippines (October 2014), China (December 2014) and Nigeria (February 2015); DR Congo (April 2015); Madagascar (May 2015) Data source: WHO/IVB Database, as of 01 June 2015, based on 35 tier 1 & 2 countries Map production Immunization Vaccines and Biologicals (IVB), World Health Organization Date of slide: 1 June 2015 The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved. Introduction* to date (30 countries or 86%) Formal commitment to introduce in 2015 (5 countries or 14%) Not applicable or not Tier 1 or 2 countries * Includes introductions in some parts of the country only

7 |7 | Middle Income Countries using IPV vaccine to date and formal/intent decision to introduce Data source: WHO/IVB Database, as of 01 June 2015 based on 100 middle income countries (MIC) as per last World Bank classification Map production Immunization Vaccines and Biologicals (IVB), World Health Organization Date of slide: 1 June 2015 The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved. Introduced* to date(33 countries or 17%) Formal commitment to introduce in 2015 (59 countries or 30%) Intend to introduce in 2015 (Fiji, Mauritius, Thailand) (3 countries or 1.5%) Formal commitment to introduce in 2016 (Angola, Egypt, Ghana, Viet Nam, Zambia) (5 countries or 2.5%) Not applicable / Not Middle Income Countries * Includes introductions in some parts of the country only Since January 2013, the following MIC have introduced IPV: Kazakhstan (July 2013); Peru (July 2013); Libya (March 2014); Albania (May 2014); Panama (July 2014); Tunisia (September 2014); Philippines (October 2014); China (December 2014); Senegal (January 2015); Serbia (January 2015); Colombia (February 2015); Maldives (March 2015) and Sudan (May 2015)

8 |8 | IPV introduction status and planned introduction by quarter by the end of 2015 Data source: WHO/IVB Database, as of 01 June 2015 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization Date of slide: 1 June 2015 The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved. Introduced* to date(89 countries or 46%) Introduction planned in June 2015(12 countries or 6%) Introduction planned in Q3 2015(32 countries or 16%) Introduction planned in Q4 2015(49 countries or 25%) Introduction planned in 2016 or planned in 2015 but month of introduction not known (12 countries or 6%) Not applicable * Includes introductions in some parts of the country only Not available Since January 2013, the following countries have introduced IPV: Kazakhstan & Peru (July 2013); Libya (March 2014); Albania (May 2014); Panama (July 2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & Nigeria (February 2015); Bangladesh & Maldives (March 2015); DPR Korea, DR Congo & Gambia (April 2015);Madagascar & Sudan (May 2015)